Search This Blog

Wednesday, January 23, 2019

BMO Capital Downgrades Merck (MRK) to Market Perform

BMO Capital analyst Alex Arfaei downgraded Merck (NYSE: MRK) from Outperform

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)